Disc Medicine, a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases,...

Real-world analysis findings highlight overall survival benefit in adolescent and young adult (AYA) newly-diagnosed acute lymphoblastic leukemia (ALL) patients treated with pediatric-inspired...

Premium Cannabis Product Brand Recognized in Four Categories in Arizona's Largest Cannabis Awards Program PHOENIX, Nov. 3, 2022 /PRNewswire/ -- Item 9 Labs—the award-winning, premium cannabis...

Under the Patronage of His Excellency the Minister of Health, we are pleased to announce the 5th Saudi Health Simulation Conference. It will be held November 6-10, 2022 at the Crowne Plaza Hotel &...

KeifeRx, LLC, an emerging clinical-stage biopharmaceutical company specializing in the discovery and development of new treatment options for neurodegenerative and immune diseases, announced today...